Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 87
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.01-072 - Targeted Delivery of a Synthetic microRNA-Based Mimic to Treat Thoracic Cancers
09:30 - 09:30 | Author(s): G. Reid
- Abstract
Loading...
-
+
P1.08 - Poster Session/ Thymoma, Mesothelioma and Other Thoracic Malignancies
- Type: Poster
- Track: Thymoma, Mesothelioma and Other Thoracic Malignancies
- Presentations: 39
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.08-039 - Adjuvant Treatment of Thymic Carcinoma
09:30 - 09:30 | Author(s): Y. Tseng
- Abstract
Loading...
-
+
ORAL 03 - New Kinase Targets
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 8
- Moderators:F. Blackhall
- Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 4a-4f
-
+
ORAL03.01 - Anlotinib as 3rd-Line Treatment for Refractory Advanced NSCLC: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
10:45 - 10:56 | Author(s): B. Han
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 06 - Next Generation Sequencing and Testing Implications
- Type: Oral Session
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 9
- Moderators:G. De Lima Lopes
- Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 1a-1f
-
+
ORAL06.06 - Impact of Reflex EGFR/ALK Testing on Time-To-Treatment and Integration of Personalized Medicine in Advanced Non-Small Cell Lung Cancer Patients
11:59 - 12:10 | Author(s): P.K. Cheema
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MINI 05 - EGFR Mutant Lung Cancer 1
- Type: Mini Oral
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 14
- Moderators:Y. Yatabe
- Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2a-3b
-
+
MINI05.01 - A Progression Free Survival Score for EGFR Mutant Non-Small Cell Lung Cancer Patients Treat with First Line EGFR Tyrosine Kinase Inhibitors
16:45 - 16:50 | Author(s): Y. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MINI05.10 - EGFR-TKI Alone or with Concomitant Radiotherapy for Brain Metastases in Lung Adenocarcinoma Patients with EGFR Gene Mutations
17:40 - 17:45 | Author(s): Y. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 102
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.01-018 - Baseline Lymphocyte-Monocyte Ratio Is a Prognostic Marker in EGFR Mutant NSCLC Patients Receiving First Line EGFR TKIs
09:30 - 09:30 | Author(s): Y. Chen
- Abstract
Loading... -
+
P2.01-024 - An ENSURE Extension Study to Evaluate 2nd Line Erlotinib and Gemcitabine/Cisplatin Cross-Over Treatment for EGFR-Mutant Chinese NSCLC Patients
09:30 - 09:30 | Author(s): Y. Wu
- Abstract
Loading...
-
+
P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 109
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.04-106 - Expression of AEG-1 Associated with Increase of TS Contributes to Chemoresistance of Pemetrexed in Lung Adenocarcinoma
09:30 - 09:30 | Author(s): C. Chen
- Abstract
Loading... -
+
P2.04-108 - The Role of miR-30c-2* in Clinical Outcome and Drug Resistance in HPV-Infected Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): Y. Cheng
- Abstract
Loading...
-
+
P2.06 - Poster Session/ Screening and Early Detection
- Type: Poster
- Track: Screening and Early Detection
- Presentations: 29
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.06-026 - Advanced Bronchoscopies for Diagnosing Precancerous or Cancerous Lesions: A Meta-Analysis
09:30 - 09:30 | Author(s): J. Zhang
- Abstract
Loading...
-
+
P2.07 - Poster Session/ Small Cell Lung Cancer
- Type: Poster
- Track: Small Cell Lung Cancer
- Presentations: 18
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.07-004 - The Relationship between UGT1A1 Gene Polymorphism and Irinotecan Effect on ED-SCLC
09:30 - 09:30 | Author(s): X. Xiaoguang
- Abstract
Loading...
-
+
ORAL 17 - EGFR Mutant Lung Cancer
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 9
- Moderators:P. Meldgaard
- Coordinates: 9/08/2015, 10:45 - 12:15, Four Seasons Ballroom F3+F4
-
+
ORAL17.02 - Randomized Trial of Gefitinib with and without Pemetrexed as First-Line Therapy in East-Asian Patients with Advanced NS NSCLC with EGFR Mutations
10:56 - 11:07 | Author(s): Y. Cheng
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
